Evidence map›Paper›PMID 40910046›Full record

ArticleFrontiers in public health2025

Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona.

Miquel Porta, José Pumarega, Ruth Aguilar, David Prieto-Merino, Laura Campi, Cristina Rius, Judit Villar-García, Marta Vidal, Alfons Jimenez, Antonio Peña and 6 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Miquel PortaSchool of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
José PumaregaSchool of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Ruth AguilarISGlobal, Barcelona, Spain.
David Prieto-MerinoUniversity of Alcalá de Henares, Madrid, Spain.
Laura CampiHospital del Mar Research Institute (IMIM), Barcelona, Spain.
Cristina RiusCIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
Judit Villar-GarcíaHospital del Mar Research Institute (IMIM), Barcelona, Spain.
Marta VidalISGlobal, Barcelona, Spain.
Alfons JimenezISGlobal, Barcelona, Spain.
Antonio PeñaUniversity of Alcalá de Henares, Madrid, Spain.
Miguel-Ángel MuñozUniversitat Pompeu Fabra, Barcelona, Spain.
Leonardo TrasandeDivision of Environmental Pediatrics, School of Medicine, New York University, New York, NY, United States.
Francisco BolúmarUniversity of Alcalá de Henares, Madrid, Spain.
Gemma Moncunill *ISGlobal, Barcelona, Spain.
Magda GasullHospital del Mar Research Institute (IMIM), Barcelona, Spain.
Carlota Dobaño *ISGlobal, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: From a public health perspective it is remarkable that there are yet no longitudinal studies in the general population investigating the influence of the basal immune state, measured before the pandemic, on the risk of SARS-CoV-2 infection and COVID-19. Objective: To investigate the specific and combined effects of personal levels of cytokines and immunoglobulins-measured in individuals' blood 4 years before the pandemic-on the risk of SARS-CoV-2 infection and COVID-19 in a general population. Methods: We conducted a prospective cohort study in 240 individuals from the general population of Barcelona. Thirty cytokines and 31 immunoglobulins were quantified in prepandemic serum samples (collected in 2016-17) by high-throughput multiplex quantitative suspension array technology. Results: Higher concentrations in 2016-17 of IL-8 and TNF- Conclusion: The unique longitudinal design of this study, with measurements before and during the pandemic in a general population, provides novel knowledge on the protective and detrimental effects of specific individual cytokines and immunoglobulins, and their mixtures, on the risk of SARS-CoV-2 seropositivity and COVID-19. If confirmed, findings would be significantly relevant for medicine and public health.

Indexed as

COVID-19CytokinesImmunoglobulinsAdultAgedFemaleHumansMaleMiddle AgedPandemicsProspective StudiesRisk FactorsSARS-CoV-2SpainCytokinesImmunoglobulinsCOVID-19cytokinesetiologyimmunoglobulinsmixturesrisk factorsSARS-CoV-2

Identifiers

PMID40910046
PMCPMC12405241

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.